Thrombin, a Key Driver of Pathological Inflammation in the Brain
Neurodegenerative diseases, including Alzheimer’s disease (AD), are major contributors to death and disability worldwide. A multitude of evidence suggests that neuroinflammation is critical in neurodegenerative disease processes. Exploring the key mediators of neuroinflammation in AD, a prototypical...
Main Authors: | Jaclyn Iannucci, Paula Grammas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/9/1222 |
Similar Items
-
Thrombin, a Mediator of Coagulation, Inflammation, and Neurotoxicity at the Neurovascular Interface: Implications for Alzheimer’s Disease
by: Jaclyn Iannucci, et al.
Published: (2020-07-01) -
Isoform-Specific Effects of Apolipoprotein E on Markers of Inflammation and Toxicity in Brain Glia and Neuronal Cells In Vitro
by: Jaclyn Iannucci, et al.
Published: (2021-05-01) -
Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse model
by: Jaclyn Iannucci, et al.
Published: (2020-12-01) -
APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
by: Rosalía Fernández-Calle, et al.
Published: (2022-09-01) -
Dabigatran reduces thrombin-induced neuroinflammation and AD markers in vitro: Therapeutic relevance for Alzheimer's disease
by: Syed Waseem Bihaqi, et al.
Published: (2021-01-01)